Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001140361-20-009203
Filing Date
2020-04-17
Accepted
2020-04-17 17:02:57
Documents
5
Effectiveness Date
2020-04-17

Document Format Files

Seq Description Document Type Size
1 DEFA14A nc10006524x2_defa14a.htm DEFA14A 39060
2 nc10006524x2_nc1.jpg GRAPHIC 2018368
3 nc10006524x2_nc2.jpg GRAPHIC 2595827
4 nc10006524x2_nc3.jpg GRAPHIC 1411130
5 nc10006524x2_nc4.jpg GRAPHIC 445226
  Complete submission text file 0001140361-20-009203.txt   6889396
Mailing Address 2100 POWELL STREET SUITE 900 EMERYVILLE CA 94608
Business Address 2100 POWELL STREET SUITE 900 EMERYVILLE CA 94608 5108485100
DYNAVAX TECHNOLOGIES CORP (Filer) CIK: 0001029142 (see all company filings)

EIN.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-34207 | Film No.: 20800406
SIC: 2834 Pharmaceutical Preparations